当前位置: 首页 > 期刊 > 《医学信息》 > 2016年第26期
编号:12961773
微颗粒在临床疾病中的研究进展(3)
http://www.100md.com 2016年7月2日 《医学信息》 2016年第26期
     [16] Muradiharan-Chari V, Clancy JW, Sedgwick A, et al. Mediators of extracellular communication during cancer progression [J]. J Cell Sci, 2010, 123 (Pt 10): 1603-1611.

    [17]Pucci F,Peter MJ. Molecular pathway: tumor-derived microvesicles and their interactions with immune cells in vivo [J]. Clin Cancer Res,2013,19(10):2598-2604.

    [18]Kalra H,Drummen GP,Mathivanan S.Focus on extracellular vesicles: introducing the next small big thing [J].Int J Mol Sci,2016,17(2).

    [19] Andaloussi S E, Mager I, Breakefield X, et al. Extracellular vesicles: biology and emerging therapeutic opportunities[J].Nature Rev Drug Discov, 2013, 12 (5): 347-357.

    [20]WangW, LiH, ZhouY, et al. Peripheral blood microvesicles are potential biomarkers for hepatocellular carcinoma [J].Cancer Biomark, 2013, 13 (5): 351-357.

    [21]Momen-Heravi F,Balaj L,Alian S,et al.Alternative methods for characterization of extracellular vesicles[J].Front Physiol.2012,7(3):354.

    [22] Jayachandran M,Miller VM,Heit JA,et al.Methodology for isolation, identification andcharacterization of microvesicles in peripheral blood [J].J Immunol Methods, 2012, 375(1-2):207-214.

    编辑/丁一, 百拇医药(冉黎)
上一页1 2 3